Interlaboratory comparison of cytomegalovirus viral load assays.
about
Human cytomegalovirus and transplantation: drug development and regulatory issuesCMV in Hematopoietic Stem Cell TransplantationCytomegalovirus and ulcerative colitis: Place of antiviral therapyCMV: Prevention, Diagnosis and TherapyClinical utility of viral load in management of cytomegalovirus infection after solid organ transplantationMulticenter evaluation of a standardized protocol for noninvasive gene expression profilingFully automated quantification of cytomegalovirus (CMV) in whole blood with the new sensitive Abbott RealTime CMV assay in the era of the CMV international standardClinical utility of bronchoalveolar lavage cytomegalovirus viral loads in the diagnosis of cytomegalovirus pneumonitis in infants.International standards and reference materials for quantitative molecular infectious disease testing.Frequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulin.Cytomegalovirus viraemia and mortality in renal transplant recipients in the era of antiviral prophylaxis. Lessons from the western Australian experience.Monitoring of human cytomegalovirus and virus-specific T-cell response in young patients receiving allogeneic hematopoietic stem cell transplantation.Human Cytomegalovirus (HCMV) - Revised.Precision across the analytical measuring range of a quantitative real-time PCR assay for cytomegalovirus detection among three clinical laboratories.Comparative evaluation of three automated systems for DNA extraction in conjunction with three commercially available real-time PCR assays for quantitation of plasma Cytomegalovirus DNAemia in allogeneic stem cell transplant recipients.Comparative evaluation of three commercial quantitative cytomegalovirus standards by use of digital and real-time PCR.Pretransplant lymphopenia is a novel prognostic factor in cytomegalovirus and noncytomegalovirus invasive infections after liver transplantationStandardization of Nucleic Acid Tests for Clinical Measurements of Bacteria and Viruses.Multicenter comparison of laboratory performance in cytomegalovirus and Epstein-Barr virus viral load testing using international standards.Cytomegalovirus in hematopoietic stem cell transplant recipientsInterpreting quantitative cytomegalovirus DNA testing: understanding the laboratory perspectiveCommutability of the First World Health Organization International Standard for Human Cytomegalovirus.Comparison of Two Commercial Automated Nucleic Acid Extraction and Integrated Quantitation Real-Time PCR Platforms for the Detection of Cytomegalovirus in PlasmaSequence Variation in Amplification Target Genes and Standards Influences Interlaboratory Comparison of BK Virus DNA Load Measurement.Efficacy of a viral load-based, risk-adapted, preemptive treatment strategy for prevention of cytomegalovirus disease after hematopoietic cell transplantation.Comparison of droplet digital PCR to real-time PCR for quantitative detection of cytomegalovirus.Utility of HTLV proviral load quantification in diagnosis of HTLV-1-associated myelopathy requires international standardization.Quantitative Assessment of Commutability for Clinical Viral Load Testing Using a Digital PCR-Based Reference StandardCommutability of Cytomegalovirus WHO International Standard in Different Matrices.Time profile of viral DNA in aqueous humor samples of patients treated for varicella-zoster virus acute retinal necrosis by use of quantitative real-time PCR.Cytomegalovirus infections in solid organ transplantation: a review.Multicenter evaluation of a commercial cytomegalovirus quantitative standard: effects of commutability on interlaboratory concordance.Automated Nucleic Acid Extraction Systems for Detecting Cytomegalovirus and Epstein-Barr Virus Using Real-Time PCR: A Comparison Study Between the QIAsymphony RGQ and QIAcube Systems.Quantitative nucleic acid amplification methods and their implications in clinical virology.Viral infections in lung transplant recipients.Strategies for managing cytomegalovirus in transplant recipients.The BK virus in renal transplant recipients-review of pathogenesis, diagnosis, and treatment.Management of viral infections in solid organ transplant recipients.Molecular diagnostics: harmonization through reference materials, documentary standards and proficiency testing.Advances in cytomegalovirus-preventive strategies in solid organ transplantation: defending pre-emptive therapy.
P2860
Q26700020-5D081E88-9E3D-465E-A95E-2F1B95F60612Q26740385-196F43BF-DA2D-44CE-904D-2AC2C9106C3BQ26766101-9430BE59-A895-4812-8BE7-5CF3AFE0E739Q26824869-3817299F-AAE1-4FB2-BAA1-C21756A8EE51Q26826856-5784ADCB-0EB0-492A-8B8D-B34B584E734CQ28679298-9B95AD35-1503-44AB-93E1-9B564A865242Q28680756-2E552468-9D29-4092-9A94-6108BA7874D7Q33626113-BF40BD49-02C3-4F4D-9C4E-44ED52E0FBC8Q33856184-98F13E5E-60D7-48B4-804C-CF6E958EF23FQ33897804-480D786C-35E2-41D8-9616-B969144416EFQ33912913-0BCB1720-BB83-40EB-8264-849B3531A7BDQ34358755-9F31702E-5901-4277-9AAA-D92651E06F77Q34625453-685CD5B1-2925-4063-BDD0-57C0A97A8460Q35139749-F5A9A316-4F15-4815-A453-1BF76110BDB0Q35139837-0DD44F4B-93CB-4044-9A9E-5FF3F98263BBQ35455475-667165BA-2C8D-473E-8FF6-A21B740E77E5Q35671545-4135108B-5329-42B3-851F-C663316B4CDAQ35757751-3D115DD9-85A9-45B4-8532-000E11ABB928Q35785478-B0CFBE36-DE0D-4D59-9B0D-BEC9626C3165Q35922928-9972AC26-DBDF-4B98-A3FE-BC37071DAA58Q35977398-9FAE60FE-3484-4527-B2EC-DA3ABBF93E11Q36066817-E65C2EA4-B615-4739-B5FB-84D78F7EEE37Q36096112-641C415B-4BD4-43F6-AFE4-4C1DA2BD6603Q36297604-6B631FDF-16A4-40EA-BBBC-41B971DF241FQ36306393-19AB7A0C-9297-4C37-A724-D1F405EE48D5Q36559052-D8EB2286-987F-44A8-BB21-A6008ED8D2A0Q36592313-76FCE022-B984-4CC1-B301-1E481FF98ED5Q36933103-AF1BABBE-1E97-42B7-A94C-EA7031AF1231Q36933144-69ACC545-F9ED-480D-B890-445B9E44557BQ36971109-E6E14D7C-DBEE-474A-BE59-CE18D3224C97Q37359332-38B62D11-C35D-4C64-BA38-655E2D39BB1EQ37470467-E0F9F81B-E12B-481E-8F53-86013D64A521Q37547775-0836D10B-E3A3-4327-9436-10AD7AD65009Q37668438-54A841E9-5A9C-4658-AF30-5D1CFB2989F9Q37721885-FCE749C7-A7A6-4A96-A5D3-B2982DD66E69Q37773992-24B8A7C6-EB10-4887-869D-153ED0699567Q37821326-E6D6CA72-340D-4FAB-B609-7CE5D24758DBQ37892559-892052CE-D3CC-4C32-8E33-C5B4FB10A592Q37929203-6AFD2F96-FC39-4CF5-9AAC-F61AE620264DQ37965695-2A0CBA3C-2056-431C-812B-945585FF57C9
P2860
Interlaboratory comparison of cytomegalovirus viral load assays.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Interlaboratory comparison of cytomegalovirus viral load assays.
@en
Interlaboratory comparison of cytomegalovirus viral load assays.
@nl
type
label
Interlaboratory comparison of cytomegalovirus viral load assays.
@en
Interlaboratory comparison of cytomegalovirus viral load assays.
@nl
prefLabel
Interlaboratory comparison of cytomegalovirus viral load assays.
@en
Interlaboratory comparison of cytomegalovirus viral load assays.
@nl
P2093
P1476
Interlaboratory comparison of cytomegalovirus viral load assays.
@en
P2093
A M Caliendo
American Society of Transplantation Infectious Diseases Community of Practice
Canadian Society of Transplantation
G G Miller
J K Preiksaitis
J M Fenton
P304
P356
10.1111/J.1600-6143.2008.02513.X
P407
P577
2009-02-01T00:00:00Z